Skip to main content
OpenTrials

Clinical trial condition

Intestinal Neoplasms

Explore clinical trials studying Intestinal Neoplasms. Study availability and eligibility vary by location and protocol.

6,346 public trials 1,367 recruiting studies
Refine in advanced search Browse all conditions

Intestinal Neoplasms trial results

Recruiting

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

NCT07540572

Conditions
Brain Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +30 more
Locations
  • Florida Clinical Trials Group Plantation, Florida, United States
  • START Astera, LLC East Brunswick, New Jersey, United States
  • START New York Long Island, LLC Lake Success, New York, United States
  • NEXT Texas LLC - Austin Austin, Texas, United States
View Trial Details
Recruiting

Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar

NCT07337590

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • University of Louisville Hospital Louisville, Kentucky, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Bryan Medical Center Lincoln, Nebraska, United States
  • Weill Cornell Medicine Colon and Rectal Surgery New York, United States
View Trial Details
Recruiting

A Study of a Urine Test to Detect Colorectal Cancer

NCT07649057

Conditions
CRC, Colonic Diseases, Colorectal Cancer, +16 more
Locations
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States
  • Korle Bu Teaching Hospital (Data Collection Only) Accra, Ghana
  • Wits Donald Gordon Medical Centre (Data Collection Only) Johannesburg, South Africa
  • Kilimanjaro Christian Medical Centre (Data Collection Only) Moshi, Tanzania
View Trial Details
Recruiting

The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer

NCT05943210

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • The University of Chicago Chicago, Illinois, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • New York Presbyterian Brooklyn Methodist Hospital Brooklyn, New York, United States
  • Weill Cornell Medical College New York, United States
View Trial Details
Recruiting

A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

NCT07058012

Conditions
Colo-rectal Cancer, Colonic Diseases, Colonic Neoplasms, +9 more
Locations
  • University of Florida Gainesville, Florida, United States
  • University of Iowa - Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
  • Missouri Baptist St Louis, Missouri, United States
View Trial Details
Recruiting

A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

NCT07011576

Conditions
Colon Cancer, Colonic Diseases, Colonic Neoplasms, +14 more
Locations
  • Rocky Mountain Cancer Center - Primary Denver, Colorado, United States
  • Illinois Cancer Specialists Arlington Heights, Illinois, United States
  • Maryland Oncology Hematology Columbia, Maryland, United States
  • Minnesota Oncology Hematology - Primary Maple Grove, Minnesota, United States
View all 14 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

NCT06051695

Conditions
Adenoma, Adnexal Diseases, Bronchial Neoplasms, +61 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Stanford University Stanford, California, United States
View Trial Details

Related conditions